{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:04:59Z","timestamp":1793329499045,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This study aims to compare the clinical outcomes of patients with <jats:italic toggle=\"yes\">de novo<\/jats:italic> chronic total occlusion (CTO) lesions treated by hybrid strategy and drug-coated balloons (DCB)-only strategy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Backgrounds<\/jats:title>\n            <jats:p>DCBs have been used as an alternative to or in combination with drug-eluting stents in CTO lesions. However, the clinical impact of DCB treatment on CTO lesion remains uncertain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We retrospectively enrolled 154 patients with <jats:italic toggle=\"yes\">de novo<\/jats:italic> CTO lesions treated by DCB, including 57 cases in hybrid group and 97 cases in DCB-only group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The lesions in hybrid group were more complicated than those in DCB-only group as shown by higher J-CTO score, and therefore higher percentage of retrograde approach, more IVUS guidance, more CTO guidewires, and longer procedural time were demonstrated. Although the percentage of non-flow-limiting dissection and residual stenosis of more than 30% were lower in hybrid group, TIMI flow grade, satisfactory and acceptable recanalization rate were not significantly different between two groups. During a median follow-up was 470 days, the incidence of target lesion revascularization (TLR), myocardial infarction and cardiac death was 11.0%, 1.3% and 1.9%, respectively. The long-term TLR-free survival was comparable between hybrid and DCB-only groups. By multivariate analysis, DCB length and age were predictors of TLR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>DCB treatment appears effective and safe in selected <jats:italic toggle=\"yes\">de novo<\/jats:italic> CTO lesions during long-term follow up. The recanalization results and long-term outcomes are comparable between hybrid and DCB-only group despite more complicated lesions in hybrid group.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001288","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T08:00:16Z","timestamp":1695024016000},"page":"555-561","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Long-term clinical outcomes of drug-coated balloon for the management of chronic total occlusions"],"prefix":"10.1097","volume":"34","author":[{"given":"Qing","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Disease"},{"name":"National Clinical Research Center for Interventional Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Disease"},{"name":"National Clinical Research Center for Interventional Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Disease"},{"name":"National Clinical Research Center for Interventional Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juying","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Disease"},{"name":"National Clinical Research Center for Interventional Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Disease"},{"name":"National Clinical Research Center for Interventional Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Disease"},{"name":"National Clinical Research Center for Interventional Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jcin.2017.05.065","article-title":"Early procedural and health status outcomes after chronic total occlusion angioplasty: a report from the OPEN-CTO registry (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures).","volume":"10","author":"Sapontis","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcin.2018.02.036","article-title":"The hybrid approach to chronic total occlusion percutaneous coronary intervention: update from the progress CTO registry.","volume":"11","author":"Tajti","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.cjco.2021.05.018","article-title":"Overview of contemporary chronic total occlusion percutaneous coronary intervention techniques: a narrative systematic review.","volume":"3","author":"Aljabbary","year":"2021","journal-title":"CJC open"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jcin.2017.01.047","article-title":"Procedural and long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion.","volume":"10","author":"Azzalini","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ihj.2018.12.003","article-title":"Procedural and follow-up clinical outcomes after chronic total occlusion revascularization: data from an Indian public hospital.","volume":"71","author":"Pillai","year":"2019","journal-title":"Indian Heart J"},{"key":"R6-20250729","first-page":"1341","article-title":"One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.","volume":"97","author":"Azzalini","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"42","DOI":"10.31083\/j.rcm2302042","article-title":"Drug-coated balloon for the management of coronary chronic total occlusions.","volume":"23","author":"Sanchez-Jimenez","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"821380","DOI":"10.3389\/fcvm.2022.821380","article-title":"Clinical outcomes of drug-coated balloon treatment after successful revascularization of de novo chronic total occlusions.","volume":"9","author":"Jun","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R9-20250729","first-page":"764","article-title":"Intraplaque wiring enables drug-coated balloons to be utilized for percutaneous recanalization of chronically occluded coronary arteries.","volume":"101","author":"Terashita","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.118.031313","article-title":"Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion.","volume":"139","author":"Lee","year":"2019","journal-title":"Circulation"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.120.046754","article-title":"Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations.","volume":"143","author":"Ybarra","year":"2021","journal-title":"Circulation"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group.","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijcard.2016.09.105","article-title":"Treatment of chronic total occlusions in native coronary arteries by drug-coated balloons without stenting - a feasibility and safety study.","volume":"225","author":"Koln","year":"2016","journal-title":"Int J Cardiol"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"e1589","DOI":"10.4244\/EIJV11I14A309","article-title":"Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the \u2018no more metallic cages\u2019 multicentre pilot experience.","volume":"11","author":"Ielasi","year":"2016","journal-title":"EuroIntervention"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5603\/CJ.a2020.0105","article-title":"Provisional drug-coated balloon treatment guided by physiology on de novo coronary lesion.","volume":"28","author":"Shin","year":"2021","journal-title":"Cardiol J"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.2147\/IJGM.S328332","article-title":"Procedural results and long-term outcomes of percutaneous coronary intervention for in-stent restenosis chronic total occlusion compared with de novo chronic total occlusion.","volume":"14","author":"Tang","year":"2021","journal-title":"Int J Gen Med"},{"key":"R17-20250729","first-page":"1016","article-title":"Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: data from 2,659 consecutive patients.","volume":"97","author":"Wang","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"R18-20250729","first-page":"893","article-title":"Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: an all-comers registry study.","volume":"93","author":"Uskela","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jcin.2019.10.062","article-title":"Percutaneous treatment and outcomes of small coronary vessels: a SCAAR report.","volume":"13","author":"Silverio","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jcin.2013.07.005","article-title":"The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.","volume":"6","author":"Costopoulos","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R22-20250729","first-page":"58","article-title":"No-reflow complicating chronic total occlusion coronary revascularization.","volume":"32","author":"Dall\u2019Ara","year":"2020","journal-title":"J Invasive Cardiol"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"935263","DOI":"10.3389\/fcvm.2022.935263","article-title":"Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions.","volume":"9","author":"Yang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"194","DOI":"10.21037\/atm.2019.05.09","article-title":"Successful treatment of complex coronary chronic total occlusions improves midterm outcomes.","volume":"7","author":"Wu","year":"2019","journal-title":"Ann Transl Med"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.carrev.2020.07.036","article-title":"A hybrid approach evaluating a drug-coated balloon in combination with a new-generation drug-eluting stent in the treatment of de novo diffuse coronary artery disease: the hyper pilot study.","volume":"28","author":"Ielasi","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"R27-20250729","first-page":"6256","article-title":"Stentless at ostium: a novel approach for treating ostial left anterior descending or left circumflex coronary artery lesions with drug-coated balloons.","volume":"14","author":"Lu","year":"2022","journal-title":"Am J Transl Res"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:02:22Z","timestamp":1753812142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001288","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,13]]}}}